Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34.
Altwegg KA, Pratap UP, Liu Z, Liu J, Sanchez JR, Yang X, Ebrahimi B, Panneerdoss DM, Li X, Sareddy GR, Viswanadhapalli S, Rao MK, Vadlamudi RK. Altwegg KA, et al. Among authors: vadlamudi rk. Breast Cancer Res Treat. 2023 Jul;200(1):151-162. doi: 10.1007/s10549-023-06958-4. Epub 2023 May 18. Breast Cancer Res Treat. 2023. PMID: 37199805 Free PMC article.
Role of PELP1/MNAR signaling in ovarian tumorigenesis.
Dimple C, Nair SS, Rajhans R, Pitcheswara PR, Liu J, Balasenthil S, Le XF, Burow ME, Auersperg N, Tekmal RR, Broaddus RR, Vadlamudi RK. Dimple C, et al. Among authors: vadlamudi rk. Cancer Res. 2008 Jun 15;68(12):4902-9. doi: 10.1158/0008-5472.CAN-07-5698. Cancer Res. 2008. PMID: 18559538
Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
Chakravarty D, Nair SS, Santhamma B, Nair BC, Wang L, Bandyopadhyay A, Agyin JK, Brann D, Sun LZ, Yeh IT, Lee FY, Tekmal RR, Kumar R, Vadlamudi RK. Chakravarty D, et al. Among authors: vadlamudi rk. Cancer Res. 2010 May 15;70(10):4092-101. doi: 10.1158/0008-5472.CAN-09-3834. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460518 Free PMC article.
Significance of ER-Src axis in hormonal therapy resistance.
Vallabhaneni S, Nair BC, Cortez V, Challa R, Chakravarty D, Tekmal RR, Vadlamudi RK. Vallabhaneni S, et al. Among authors: vadlamudi rk. Breast Cancer Res Treat. 2011 Nov;130(2):377-85. doi: 10.1007/s10549-010-1312-2. Epub 2010 Dec 24. Breast Cancer Res Treat. 2011. PMID: 21184269 Free PMC article.
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Chakravarty D, et al. Among authors: vadlamudi rk. Clin Cancer Res. 2011 Apr 15;17(8):2250-9. doi: 10.1158/1078-0432.CCR-10-2718. Epub 2011 Mar 18. Clin Cancer Res. 2011. PMID: 21421858 Free PMC article.
Regulation of rDNA transcription by proto-oncogene PELP1.
Gonugunta VK, Nair BC, Rajhans R, Sareddy GR, Nair SS, Vadlamudi RK. Gonugunta VK, et al. Among authors: vadlamudi rk. PLoS One. 2011;6(6):e21095. doi: 10.1371/journal.pone.0021095. Epub 2011 Jun 13. PLoS One. 2011. PMID: 21695158 Free PMC article.
Significance of PELP1 in ER-negative breast cancer metastasis.
Roy S, Chakravarty D, Cortez V, De Mukhopadhyay K, Bandyopadhyay A, Ahn JM, Raj GV, Tekmal RR, Sun L, Vadlamudi RK. Roy S, et al. Among authors: vadlamudi rk. Mol Cancer Res. 2012 Jan;10(1):25-33. doi: 10.1158/1541-7786.MCR-11-0456. Epub 2011 Nov 15. Mol Cancer Res. 2012. PMID: 22086908 Free PMC article.
188 results